CSU spinoff hopes to bring dog cancer drug to market by 2014

A spinoff of Colorado State University called the Veterinary Emerging Technologies Development Corp., or VetDC, hopes to leverage a $200,000 investment from a nonprofit created to boost the state's biotech industry into enough money to launch trials of a promising chemotherapy drug to treat lymphoma in dogs. About 1.2 million dogs are diagnosed with cancer annually, about 200,000 of them with lymphoma, an aggressive cancer that's often fatal.

View Full Article in:

Coloradoan (Fort Collins, Colo.) (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel
Cardinal Health
Columbus, OH
Regulatory Affairs Specialist
Stryker
Mahwah, NJ
Sr. Principal OptoMechanical Engineer - 14000008M2
Abbott
San Jose, CA
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Sr. Principal Electrical Engineer - 14000008LR
Abbott
San Jose, CA